technetium 99m has been researched along with Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altai, M; Andersson, KG; Garousi, J; Löfblom, J; Mitran, B; Orlova, A; Oroujeni, M; Steinhardt, X; Tolmachev, V; Vorobyeva, A | 1 |
Altai, M; Buijs, J; Chernov, V; Deyev, S; Garousi, J; Güler, R; Löfblom, J; Mitran, B; Orlova, A; Proshkina, G; Schulga, A; Tolmachev, V; Vorobyeva, A | 1 |
2 other study(ies) available for technetium 99m and Neoplasms
Article | Year |
---|---|
Influence of composition of cysteine-containing peptide-based chelators on biodistribution of
Topics: Animals; Cell Line, Tumor; Chelating Agents; Cysteine; ErbB Receptors; Humans; Mice; Molecular Imaging; Molecular Probes; Neoplasm Transplantation; Neoplasms; Peptides; Recombinant Fusion Proteins; Technetium; Tissue Distribution | 2018 |
Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties.
Topics: Animals; Ankyrin Repeat; Ankyrins; Cell Line, Tumor; Female; Humans; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Imaging; Neoplasms; Protein Binding; Radionuclide Imaging; Receptor, ErbB-2; Single Photon Emission Computed Tomography Computed Tomography; Technetium; Tissue Distribution; Xenograft Model Antitumor Assays | 2019 |